

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Approved FDF
Sponsor : Akebia Therapeutics
Deal Size : Inapplicable
Deal Type : Inapplicable
AVEROA Gains EMA Positive Opinion for XOANACYL in Chronic Kidney Disease
Details : Xoanacyl (ferric citrate) is an oral therapy offering a dual mechanism of action for patients with CKD. Xoanacyl has been approved and is being commercialized in US under the brand name Auryxia.
Product Name : Xoanacyl
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
April 02, 2025
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Approved FDF
Sponsor : Akebia Therapeutics
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Innovent Announces Primary Endpoint Met in Phase 2 of IBI302 in Neovascular AMD Treatment
Details : AVA1014 (ferric citrate coordination complex) is an iron containing phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
April 23, 2024
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Ferric Citrate
Therapeutic Area : Hematology
Study Phase : Phase III
Sponsor : Akebia Therapeutics
Deal Size : Inapplicable
Deal Type : Inapplicable
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
Details : Ferric Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Anemia, Iron-Deficiency.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
October 20, 2021
Lead Product(s) : Ferric Citrate
Therapeutic Area : Hematology
Highest Development Status : Phase III
Sponsor : Akebia Therapeutics
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase IV
Sponsor : Akebia Therapeutics
Deal Size : Inapplicable
Deal Type : Inapplicable
Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants
Details : Ferric Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hyperphosphatemia.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
June 10, 2021
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Sponsor : Akebia Therapeutics
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ferric Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Anemia-associated with Renal Insufficiency, Chronic.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 02, 2020
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD
Details : Ferric Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Anemia-associated with Renal Insufficiency, Chronic.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
September 10, 2020
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ferric Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hyperphosphatemia-associated with Renal Insufficiency, Chronic.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
August 24, 2020
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ferric Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hyperphosphatemia.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
July 07, 2020
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ferric Citrate
Therapeutic Area : Hematology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The COMPASS trial was designed to investigate the efficacy and safety of dosing ferric citrate twice-daily as compared to the current U.S. FDA approved dosing of ferric citrate three times daily in adult patients with chronic kidney disease (CKD) not on ...
Product Name : Auryxia
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
June 10, 2020
Lead Product(s) : Ferric Citrate
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ferric Citrate
Therapeutic Area : Hematology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The NDA is based on JT and Torii's Phase 3 clinical study and other clinical studies in adult patients with IDA in Japan.
Product Name : Auryxia
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 18, 2020
Lead Product(s) : Ferric Citrate
Therapeutic Area : Hematology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
